Search Results - "Liao, Jason"

Refine Results
  1. 1

    Dynamic RMST curves for survival analysis in clinical trials by Liao, Jason J Z, Liu, G Frank, Wu, Wen-Chi

    Published in BMC medical research methodology (27-08-2020)
    “…The data from immuno-oncology (IO) therapy trials often show delayed effects, cure rate, crossing hazards, or some mixture of these phenomena. Thus, the…”
    Get full text
    Journal Article
  2. 2

    A gated group sequential design for seamless Phase II/III trial with subpopulation selection by Miao, Guanhong, Liao, Jason J Z, Yang, Jing, Anderson, Keaven

    Published in BMC medical research methodology (03-01-2023)
    “…Due to the high cost and high failure rate of Phase III trials where a classical group sequential design (GSD) is usually used, seamless Phase II/III designs…”
    Get full text
    Journal Article
  3. 3

    A hybrid design for dose‐finding oncology clinical trials by Liao, Jason J. Z., Zhou, Feng, Zhou, Heng, Petruzzelli, Lilli, Hou, Kevin, Asatiani, Ekaterine

    Published in International journal of cancer (01-11-2022)
    “…Identifying the maximum tolerated dose (MTD) and recommending a Phase II dose for an investigational treatment is crucial in cancer drug development. A…”
    Get full text
    Journal Article
  4. 4

    A flexible parametric survival model for fitting time to event data in clinical trials by Liao, Jason J.Z., Liu, Guanghan Frank

    “…Time‐to‐event data are common in clinical trials to evaluate survival benefit of a new drug, biological product, or device. The commonly used parametric models…”
    Get full text
    Journal Article
  5. 5

    Optical I/O Technology for Tera-Scale Computing by Young, I.A., Mohammed, E., Liao, J.T.S., Kern, A.M., Palermo, S., Block, B.A., Reshotko, M.R., Chang, P.L.D.

    Published in IEEE journal of solid-state circuits (01-01-2010)
    “…This paper describes both a near term and a long term optical interconnect solution, the first based on a packaging architecture and the second based on a…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Three steps toward dose optimization for oncology dose finding by Liao, Jason J.Z., Asatiani, Ekaterine, Liu, Qingyang, Hou, Kevin

    “…Traditional dose selection for oncology registration trials typically employs a one- or two-step single maximum tolerated dose (MTD) approach. However, this…”
    Get full text
    Journal Article
  7. 7

    Approximate confidence limit for the reference scaled bioequivalence with a parallel design by Liao, Jason J.Z., Li, Yifang

    Published in Journal of biopharmaceutical statistics (03-03-2020)
    “…The reference scaled bioequivalence has been proposed with many successful applications for the highly variable products. The statistical properties for the…”
    Get full text
    Journal Article
  8. 8

    Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages by Linton, Samuel S, Abraham, Thomas, Liao, Jason, Clawson, Gary A, Butler, Peter J, Fox, Todd, Kester, Mark, Matters, Gail L

    Published in PloS one (01-11-2018)
    “…Pancreatic ductal adenocarcinoma (PDAC) tumor growth is enhanced by tumor-associated macrophages (TAMs), yet the mechanisms by which tumor cells and TAMs…”
    Get full text
    Journal Article
  9. 9

    Mixture survival trees for cancer risk classification by Jia, Beilin, Zeng, Donglin, Liao, Jason J. Z., Liu, Guanghan F., Tan, Xianming, Diao, Guoqing, Ibrahim, Joseph G.

    Published in Lifetime data analysis (01-07-2022)
    “…In oncology studies, it is important to understand and characterize disease heterogeneity among patients so that patients can be classified into different risk…”
    Get full text
    Journal Article
  10. 10

    Analysis of time-to-event data using a flexible mixture model under a constraint of proportional hazards by Liu, Guanghan Frank, Liao, Jason J. Z.

    Published in Journal of biopharmaceutical statistics (02-09-2020)
    “…Cox proportional hazards (PH) model evaluates the effects of interested covariates under PH assumption without specified the baseline hazard. In clinical trial…”
    Get full text
    Journal Article
  11. 11

    Inferring latent heterogeneity using many feature variables supervised by survival outcome by Jia, Beilin, Zeng, Donglin, Liao, Jason J. Z., Liu, Guanghan F., Tan, Xianming, Diao, Guoqing, Ibrahim, Joseph G.

    Published in Statistics in medicine (15-06-2021)
    “…In cancer studies, it is important to understand disease heterogeneity among patients so that precision medicine can particularly target high‐risk patients at…”
    Get full text
    Journal Article
  12. 12

    Incidental Internal Mammary Lymph Nodes Visualized on Screening Breast MRI by Mack, Meghan, Chetlen, Alison, Liao, Jason

    Published in American journal of roentgenology (1976) (01-07-2015)
    “…The frequency of visualization and size of internal mammary lymph nodes in women undergoing high-risk screening breast MRI is unknown. When these nodes are…”
    Get full text
    Journal Article
  13. 13

    Sample size allocation in multiregional equivalence studies by Liao, Jason J.Z., Yu, Ziji, Li, Yulan

    “…With the increasing globalization of drug development, the multiregional clinical trial (MRCT) has gained extensive use. The data from MRCTs could be accepted…”
    Get full text
    Journal Article
  14. 14

    New insight into Epstein-Barr virus infection using models of stratified epithelium by Hayman, Ian R, Temple, Rachel M, Burgess, Cole K, Ferguson, Mary, Liao, Jason, Meyers, Craig, Sample, Clare E

    Published in PLoS pathogens (01-01-2023)
    “…Epstein-Barr virus (EBV) is a ubiquitous human pathogen that is transmitted in saliva. EBV transits through the oral epithelium to infect B cells, where it…”
    Get full text
    Journal Article
  15. 15

    Comparability of critical quality attributes for establishing biosimilarity by Liao, Jason J.Z., Darken, Patrick F.

    Published in Statistics in medicine (10-02-2013)
    “…To develop a biosimilar product, it is essential to demonstrate the biosimilarity between the proposed biosimilar product and the reference product first in…”
    Get full text
    Journal Article
  16. 16

    Using artificial intelligence tools in answering important clinical questions: The KEYNOTE-183 multiple myeloma experience by Liao, Jason J.Z., Farooqui, Mohammed Z.H., Marinello, Patricia, Hartzel, Jonathan, Anderson, Keaven, Ma, Junshui, Gause, Christine K.

    Published in Contemporary clinical trials (01-12-2020)
    “…The phase III, randomized, active-controlled, multicenter, open-label KEYNOTE-183 study (NCT02576977) evaluating pomalidomide and low dose dexamethasone…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b by Qin, Albert, Wu, Daoxiang, Liao, Jason, Xie, Shuping, Chen, Haoqi, Gao, Yucheng, Cui, Jie, Su, Xia, Miyachi, Narihisa, Sato, Toshiaki, Li, Yaning, Zhang, Jingjing, Shen, Weihong, Wang, Wei

    Published in Frontiers in pharmacology (24-09-2024)
    “…Ropeginterferon alfa-2b (Ropeg) is approved for the treatment of adults with polycythemia vera (PV). This report aims to analyze the ethnic sensitivity of…”
    Get full text
    Journal Article
  19. 19

    Design and Implementation of an IoT Acoustic-Controlled Pillow for Sleep Health Monitoring by Liao, Jason K., Lai, Chun Yin, Chan, Chetwyn Che Hin, Mung, Steve W. Y.

    Published in IEEE sensors letters (01-09-2024)
    “…This letter introduces an Internet of Things (IoT) acoustic-controlled pillow to reduce environmental noise, monitor snoring, and mitigate insomnia symptoms…”
    Get full text
    Journal Article
  20. 20

    Details of the Collagen and Elastin Architecture in the Human Limbal Conjunctiva, Tenon's Capsule and Sclera Revealed by Two-Photon Excited Fluorescence Microscopy by Park, Choul Yong, Marando, Catherine M, Liao, Jason A, Lee, Jimmy K, Kwon, Jiwon, Chuck, Roy S

    “…To investigate the architecture and distribution of collagen and elastin in human limbal conjunctiva, Tenon's capsule, and sclera. The limbal conjunctiva,…”
    Get full text
    Journal Article